Welcome
Astex is the world leader in fragment-based drug discovery - the most important advance in drug discovery chemistry in the last 20 years.
Our pre-eminent position in this field is underlined by:
- The productivity of our discovery engine which has delivered five novel drug candidates into development in four years - three of which are now in clinical trials with another two in preclinical development.
- Multiple collaborations in various therapeutic areas with leading pharmaceutical companies such as Janssen Pharmaceutica and Novartis that collectively have headline potential deal value in excess of $1.6 billion for Astex.
- World-class science that has been published in leading journals such as Nature, Science and the Journal of Medicinal Chemistry, with some of our papers being among the most cited in their field.
Follow this link for Astex presentations at recent meetings.